Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms

Background: Thyroid receptors, TRα and TRβ, are involved in important physiological functions such as metabolism, cholesterol level and heart activities. Whereas metabolism increase and cholesterol level lowering could be achieved by TRβ isoform activation, TRα activation affects heart rates. Therefore, β-selective thyromimetics have been developed as promising drug-candidates for treatment of obesity and elevated cholesterol level. GC-1 [3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)-phenoxy acetic acid] has ability to lower LDL cholesterol with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than atorvastatin (Lipitor©) in studies in rats, mice and monkeys. Results: To investigate GC-1 specificity, we solved crystal structures and performed molecular dynamics simulations of both isoforms complexed with GC-1. Crystal structures reveal that, in TRα Arg228 is observed in multiple conformations, an effect triggered by the differences in the interactions between GC-1 and Ser277 or the corresponding asparagine (Asn331) of TRβ. The corresponding Arg282 of TRβ is observed in only one single stable conformation, interacting effectively with the ligand. Molecular dynamics support this model: our simulations show that the multiple conformations can be observed for the Arg228 in TRα, in which the ligand interacts either strongly with the ligand or with the Ser277 residue. In contrast, a single stable Arg282 conformation is observed for TRβ, in which it strongly interacts with both GC-1 and the Asn331. Conclusion: Our analysis suggests that the key factors for GC-1 selectivity are the presence of an oxyacetic acid ester oxygen and the absence of the amino group relative to T3. These results shed light into the β-selectivity of GC-1 and may assist the development of new compounds with potential as drug candidates to the treatment of hypercholesterolemia and obesity

GQ-16, a novel peroxisome proliferator-activated receptor (PPAR ) ligand, promotes insulin sensitization without weight gain

ABSTRACTBackground: PPAR agonists improve insulin sensitivity but also evoke weight gain. Results: GQ-16 is a PPAR partial agonist that blocks receptor phosphorylation by Cdk5 and improves insulin sensitivity in diabetic mice in the absence of weight gain. Conclusion: The unique binding mode of GQ-16 appears to be responsible for the compound’s advantageous pharmacological profile. Significance: Similar compounds could have promise as anti-diabetic therapeutics

Dissecting the Relation between a Nuclear Receptor and GATA: Binding Affinity Studies of Thyroid Hormone Receptor and GATA2 on TSHβ Promoter

Background: Much is known about how genes regulated by nuclear receptors (NRs) are switched on in the presence of a ligand. However, the molecular mechanism for gene down-regulation by liganded NRs remains a conundrum. The interaction between two zinc-finger transcription factors, Nuclear Receptor and GATA, was described almost a decade ago as a strategy adopted by the cell to up-or down-regulate gene expression. More recently, cell-based assays have shown that the Zn-finger region of GATA2 (GATA2-Zf) has an important role in down-regulation of the thyrotropin gene (TSH beta) by liganded thyroid hormone receptor (TR). Methodology/Principal Findings: In an effort to better understand the mechanism that drives TSH beta down-regulation by a liganded TR and GATA2, we have carried out equilibrium binding assays using fluorescence anisotropy to study the interaction of recombinant TR and GATA2-Zf with regulatory elements present in the TSH beta promoter. Surprisingly, we observed that ligand (T3) weakens TR binding to a negative regulatory element (NRE) present in the TSH beta promoter. We also show that TR may interact with GATA2-Zf in the absence of ligand, but T3 is crucial for increasing the affinity of this complex for different GATA response elements (GATA-REs). Importantly, these results indicate that TR complex formation enhances DNA binding of the TR-GATA2 in a ligand-dependent manner. Conclusions: Our findings extend previous results obtained in vivo, further improving our understanding of how liganded nuclear receptors down-regulate gene transcription, with the cooperative binding of transcription factors to DNA forming the core of this process.Medical Research Council (MRC), UKConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazi

Crystal structure and regulation of the citrus pol III repressor MAF1 by auxin and phosphorylation

MAF1 is the main RNA polymerase (Pol) III repressor that controls cell growth in eukaryotes. The Citrus ortholog, CsMAF1, was shown to restrict cell growth in citrus canker disease but its role in plant development and disease is still unclear. We solved the crystal structure of the globular core of CsMAF1, which reveals additional structural elements compared with the previously available structure of hMAF1, and explored the dynamics of its flexible regions not present in the structure. CsMAF1 accumulated in the nucleolus upon leaf excision, and this translocation was inhibited by auxin and by mutation of the PKA phosphorylation site, S45, to aspartate. Additionally, mTOR phosphorylated recombinant CsMAF1 and the mTOR inhibitor AZD8055 blocked canker formation in normal but not CsMAF1-silenced plants. These results indicate that the role of TOR on cell growth induced by Xanthomonas citri depends on CsMAF1 and that auxin controls CsMAF1 interaction with Pol III in citrusThis work was supported by Sa˜ o Paulo Research Foundation (FAPESP grant 2011/20468-1). C.E.B. and A.F.Z.N. received a fellowship from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).Peer reviewe

Thyroid hormone receptor oligomerization, low resolution structures, DNA and ligand binding

Os receptores tireoidianos (TRs) são proteínas envolvidas em várias funções fisiológicas importantes para os organismos, pois são potentes reguladores do desenvolvimento, divisão e diferenciação celular, metabolismo e homeostase. Eles são responsáveis pela regulação da transcrição de genes-alvo específicos, mediando efeitos pleiotrópicos de hormônios lipofílicos nas células. Na ausência de ligantes essas proteínas estão complexadas a correpressores, impedindo a transcrição de genes por elas regulados. Por outro lado, a presença do ligante induz à transcrição através da ligação a elementos responsivos do DNA e coativadores. Nesse trabalho alguns aspectos do TR foram evidenciados, permintindo-se um melhor conhecimento acerca do funcionamento e estrutura desse receptor. Os experimentos de oligomerização revelaram a presença dos tetrâmeros do TR, os quais estavam restritos ao Receptor X Retinóico, sugerindo mecanismos novos na regulação do receptor. Os ensaios de raios-X a baixos ângulos resultaram nos primeiros modelos estruturais de baixa resolução de construções maiores do TR, demonstrando o correto posicionamento de seus domínios em sua estrutura geral, o que forneceu informações importantes sobre sua estrutura geral. Os experimentos de fluorescência avaliaram a ligação desses receptores a diversos elementos responsivos, em termos de constantes de dissociação e seletividade para cada um deles. E, por fim, os experimentos de troca de hidrogênio por deutério revelaram a movimentação que ocorre no domínio de ligação do ligante do receptor antes e após a adição do ligante T3. Esses resultados ampliam um pouco mais os conhecimentos sobre os mecanismos de ação e sobre a estrutura quaternária dos TR, promovendo um melhor entendimento dos conceitos básicos envolvidos na atuação dessas macromoléculas, as quais estão inseridas em redes complexas de regulação e interação com outras proteínas.The thyroid receptors (TRs) are proteins, which are involved in diverse and important physiological functions in the organisms, since they are regulators of development, cell divison and differentiation, metabolism and homeostasis. They are responsible by the regulation of specific gene transcription, through pleiotropic effects of lipophilic hormones in the cells. In the absence of the ligand these proteins are complexed to correpressors and block the transcription of genes that are regulated by them On the other hand, in the presence of the ligand transcription is induced through the binding of the receptors to DNA response elements and coactivators. New findings about TR described in this study helped to improve the understanding of the function and structure of the receptor. This was accomplished by: oligomerization experiments which showed the presence of TR tetramers, a quarternary structure described before only for the Retinoid Receptor X, and suggested new regulation mechanisms for the receptors; the small angle X-ray scattering assays which resulted in the first low resolution structural models of bigger constructions of TR, showing the correct position of TR domains and providing important information about the global TR structure; the anisotropy fluorescence experiments which evaluated the binding of these receptors to diverse response elements, in terms of dissociation constants and selectivity for each one of the HREs tested; and finally, the hydrogen/deuterium experiments which revealed the ligand binding domain mobility before and after the ligand addition. In summary, we can say that these results all together extended the knowledge about the TR action mechanisms and its quarternary strucuture, providing better understanding of the basic concepts involved in these macromolecules behavior, which are inserted into a complex network of regulation and interaction with other proteins

Cellular and Biophysical Pipeline for the Screening of Peroxisome Proliferator-Activated Receptor Beta/Delta Agonists: Avoiding False Positives

Peroxisome proliferator-activated receptor beta/delta (PPARß/δ) is considered a therapeutic target for metabolic disorders, cancer, and cardiovascular diseases. Here, we developed one pipeline for the screening of PPARß/δ agonists, which reduces the cost, time, and false-positive hits. The first step is an optimized 3-day long cellular transactivation assay based on reporter-gene technology, which is supported by automated liquid-handlers. This primary screening is followed by a confirmatory transactivation assay and by two biophysical validation methods (thermal shift assay (TSA) and (ANS) fluorescence quenching), which allow the calculation of the affinity constant, giving more information about the selected hits. All of the assays were validated using well-known commercial agonists providing trustworthy data. Furthermore, to validate and test this pipeline, we screened a natural extract library (560 extracts), and we found one plant extract that might be interesting for PPARß/δ modulation. In conclusion, our results suggested that we developed a cheaper and more robust pipeline that goes beyond the single activation screening, as it also evaluates PPARß/δ tertiary structure stabilization and the ligand affinity constant, selecting only molecules that directly bind to the receptor. Moreover, this approach might improve the effectiveness of the screening for agonists that target PPARß/δ for drug development

Nuclear Receptor Research: Contributions from Latin America

The fact that virtually every single aspect of cell function and the complex network of regulatory processes in an organism involve crucial roles by nuclear receptors is not surprising at the present time. Accordingly, thousands of studies are published every year in hundreds of journals with very broad spectra, making it difficult for researchers in the field to find specific information of interest to them. This is the reason why Nuclear Receptor Research was born; to gather in one journal most of the advances covering all facets of this cardinal group of regulatory transcription factors.Fil: Napimoga, Marcelo Henrique. São Leopoldo Mandic Institute and Research Center. Laboratory of Immunology and Molecular Biology; BrasilFil: Galigniana, Mario Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); ArgentinaFil: Migliorini Figueira, Ana Carolina. Brazilian Center for Research in Energy and Materials. Brazilian Biosciences National Laboratory; BrasilFil: Onate, Sergio A. . Universidad de Concepción; ChileFil: Castro Obregon, Susana. Universidad Nacional Autónoma de México. Instituto de Fisiología Celular; Méxic

Thyroid Hormone Receptor (TR) on negative regulatory element (NRE) in TSHβ promoter.

<p><b>A</b> – Schematic structure of the TSHβ promoter: The binding sites for GATA2, TATA box, and reported NRE. <b>B</b> – Fluorescence anisotropy curve of binding TR DL (black dots), T3/TR DL (white dots) and T3/TR DL+RXR DL to fluorophore-labelled sequence TSH NRE (black triangles). Protein titrations were made from 1 to 10000nM on 10nM of fluorescence.</p

TR DL and GATA2-Zf on TSH GATA-RE from TSHβ promoter.

<p>Fluorescence anisotropy curve of binding unliganded TR DL (black dots), GATA-2 (white dots), unliganded TR DL+GATA2-Zf complex (inverted black triangles), T3/TR DL+GATA2-Zf (black triangles) and T3/TR DL (grey triangles) to 10 nM of fluorophore-labelled sequence TSH GATA-RE DNA. All curves were made separately; being each protein titrated on the DNA, in a concentration range of 1 to 10000nM.</p

TR DL and GATA2-Zf on canonical GATA-RE.

<p>Fluorescence anisotropy curve of binding unliganded TR DL (black dots), GATA2-Zf (white dots), unliganded TR DL+GATA2-Zf complex (inverted black triangles), T3/TR DL+GATA2-Zf (black triangles) and T3/TR DL (grey triangles) to 10nM of fluorophore-labelled sequence GATA-RE. All curves were made separately; being each protein titrated on the DNA, in a concentration range of 1 to 10000nM.</p